VAERS reports by lot

Moderna COVID-19 lot 044C22A: VAERS reports

98 VAERS reports list lot 044C22A as a Moderna COVID-19 vaccine, received between 2022-08-05 and 2024-02-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
98
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1320%
Cardiac / Cardiovascular1218%
Respiratory1218%
Neurological812%
Musculoskeletal711%
Gastrointestinal58%
Allergic / Anaphylactic35%
Dermatological (non-injection-site)23%
Thrombotic / Hematological12%
Psychiatric / Neuropsychiatric12%
Injection-site / Local reaction12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas25
Maryland8
California8
Oklahoma6
Idaho4
Ohio3
Kansas3
Arizona3
Kentucky3
Alabama2
Minnesota2
Oregon2

Reports by month received

2022-088
2022-0921
2022-104
2022-113
2022-127
2023-017
2023-022
2023-035
2023-0434
2023-053
2023-083
2024-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.